CHU Nantes - Hopital Nord Laënnec

Saint-Herblain, Loire Atlantique 44800

0 studies enrolling now · 3 studies all time

What they study most

Alzheimer's Disease, Alzheimer's Disease Dementia, Brain Edema, Mild Cognitive Impairment Due to Alzheimer's Disease, Stroke, Acute

Studies at this site

• A Study to Learn About the Safety of Diranersen (BIIB080) Injections and Whether They Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of Age — Running, not enrolling
• A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease — Stopped early
• Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction — Stopped early